AI assistant
Sending…
Oncopeptides — Major Shareholding Notification 2020
May 11, 2020
3091_iss_2020-05-11_6bd98f59-e087-4728-8cba-10d8b5dfa598.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Oncopeptides AB
Holder
C WorldWide Asset Management Fondsmæglerselskab A/S
Instrument
Instrument Common stock SE0009414576 Before the transaction Shares 2,551,596 Voting rights 2,551,596 Transaction Reason for major shareholding notification Other Date 06/05/2020 Limit for number of shares 5 % Limit for number of votes 5 % After the transaction Quantity Shares 3,101,596 Directly held voting rights 3,101,596 Indirectly held voting rights 0 Percentage Directly held shares 5.04502 % Directly held voting rights 5.04502 % Indirectly held voting rights 0 %
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|||
|---|---|---|---|---|
| Shares | 5.04502 % | 3,101,596 | ||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
||||
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||||
| - Physically settled | ||||
| - Cash settled | ||||
| Total | 5.04502 % | 3,101,596 | ||
| When voting by proxy, the former voting rights holders are | |||||
|---|---|---|---|---|---|
| Name | Voting rights End date | ||||
| C WorldWide Fund Management S.A. | 3,101,596 | ||||
| Group total holdings | |||||
| Voting rights | 3,101,596 | ||||
| Percentage of voting rights 5.04502 | |||||
| Notes (other relevant informations according to law) |
Change due to: Additional Offering.
Published
11/05/2020 15:02
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 16